Boston Scientific Executive Expects Top-Line Pressure Through 2027
The executive said pressure is expected to persist and make revenue and EPS growth challenging, excluding the Penumbra deal.
Story updates
12:44:35 PM UTC
SquawkNews
BOSTON SCIENTIFIC EXEC SAYS CO EXPECTS TO CLOSE PENUMBRA DEAL IN EARLY Q1 2027